BCHE and Alzheimer disease: Presently, for the treatment of mild to moderate AD, cholinesterase inhibitors (i.e., donepezil, rivastigmine, and galantamine) are used, whereas the N-methyl-D-aspartate (NMDA) receptor antagonist (i.e., memantine) is used for the treatment of severe cases of AD [167].